Decreased fibronectin in rat liver altered foci and adenomas induced by N-2-fluorenylacetamide. 1988

H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
American Health Foundation, Valhalla, New York.

The disposition of fibronectin in N-2-fluorenylacetamide-induced rat liver lesions was studied by immunohistochemical staining. Male rats were fed the carcinogen for 7 weeks to induce hepatocellular altered foci and then given no chemical or phenobarbital in the diet for 24 weeks until adenomas developed. Regardless of the exposure conditions, the amount of extracellular fibronectin was unchanged in about 60% of the liver altered foci and decreased in about 40%. In contrast, 90% of the adenomas demonstrated a significantly decreased staining pattern for fibronectin. In some adenomas, the fibronectin staining pattern demonstrated irregular, wide, and distorted deposits. In nonlesional regions of the livers of rats exposed to N-2-fluorenylacetamide, the amount of fibronectin was decreased in the centrilobular and midlobular zones. The decrease of fibronectin in hepatocellular altered foci and adenomas demonstrates another abnormality in these lesions, which may be important in their biologic behavior. Foci with decreased fibronectin may have a greater potential to progress to adenomas.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015073 2-Acetylaminofluorene A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. 2-Acetamidofluorene,Fluoren-2-ylacetamide,2-AAF,2-Fluorenylacetamide,AAF, Aminofluorene,Acetylaminofluorene,N-2-Fluorenylacetamide,N-Acetyl-2-Aminofluorene,2 Acetamidofluorene,2 Acetylaminofluorene,2 Fluorenylacetamide,Aminofluorene AAF,Fluoren 2 ylacetamide,N 2 Fluorenylacetamide,N Acetyl 2 Aminofluorene
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
December 1982, Journal of the National Cancer Institute,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
March 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
January 1981, Carcinogenesis,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
October 1981, Gan,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
October 1969, Chemico-biological interactions,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
October 1965, Biochimica et biophysica acta,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
January 1978, Biochemical pharmacology,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
June 1984, Carcinogenesis,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
October 1972, Cancer research,
H Maruyama, and T Tanaka, and R Gebhardt, and L Berghem, and G M Williams
May 1976, Cancer biochemistry biophysics,
Copied contents to your clipboard!